Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients. Mallinckrodt’s growing portfolio of specialty pharmaceuticals and global medical imaging products has expanded to help treat a wide variety of health conditions, from pain to central nervous system disorders to autoimmune and rare diseases. To see what sets Mallinckrodt apart, take a look at our distinctive approach to solving complex challenges with unique solutions.
People throughout the world count on Mallinckrodt products every day to help them lead healthier lives. That’s why we proudly stand by the three values we have held for nearly 150 years: to produce quality products with the utmost integrity and unparalleled service in order to better serve the patients, customers and communities in which we live and work. Explore the roles of our dedicated employees and our commitment to responsibility.[/td_text_with_title]
Specialty biopharmaceutical company to establish state-of-the-art Dublin manufacturing Facility – up to 45 skilled pharmaceutical jobs to be created DUBLIN, May 20, 2015 –Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced a €45million investment to expand its Dublin-based operations. A new state-of-the-art manufacturing facility and office building are to be located at College […]
Mallinckrodt Completes Acquisition Of Ikaria for approximately $2.3 billion Transaction expected to be accretive to Mallinckrodt’s fiscal 2015 adjusted diluted earnings per share Accelerates Mallinckrodt’s growth in specialty brands; adds portfolio diversity with high-value, high-margin INOMAX Total Care™ offering; further enlarges and diversifies Hospital growth platform with strong presence in neonatal intensive care Augments Specialty […]